Arkolith/Insider Trading/ZIVO/Form 4

Strome Mark E

10% OwnerZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Apr 24, 2026
Net Buying
Open-Market Buys
$200K
Open-Market Sells
$0
Net Open-Market Flow
$200K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2026Buy(P)100K$2.00$200K573K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-047650) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML